Celsius (NASDAQ:CELH – Free Report) had its price objective lowered by Roth Mkm from $43.00 to $40.00 in a research report released on Thursday,Benzinga reports. The brokerage currently has a buy rating on the stock.
A number of other research analysts have also weighed in on the stock. UBS Group cut their target price on shares of Celsius from $50.00 to $45.00 and set a “buy” rating for the company in a research report on Thursday. Maxim Group cut their price objective on Celsius from $65.00 to $50.00 and set a “buy” rating for the company in a research report on Thursday, September 5th. Piper Sandler reduced their price objective on Celsius from $50.00 to $47.00 and set an “overweight” rating for the company in a research report on Tuesday, September 24th. Bank of America dropped their target price on shares of Celsius from $32.00 to $26.00 and set an “underperform” rating on the stock in a research report on Thursday, September 5th. Finally, B. Riley cut their target price on shares of Celsius from $50.00 to $47.00 and set a “buy” rating for the company in a research note on Monday, November 4th. One analyst has rated the stock with a sell rating, three have issued a hold rating and eleven have issued a buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $54.40.
View Our Latest Stock Report on Celsius
Celsius Trading Down 3.7 %
Insider Transactions at Celsius
In related news, CEO John Fieldly sold 74,847 shares of the business’s stock in a transaction on Thursday, September 12th. The stock was sold at an average price of $32.80, for a total value of $2,454,981.60. Following the sale, the chief executive officer now owns 1,812,490 shares of the company’s stock, valued at $59,449,672. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 2.20% of the stock is currently owned by insiders.
Institutional Investors Weigh In On Celsius
Hedge funds have recently made changes to their positions in the company. S.A. Mason LLC bought a new stake in Celsius during the second quarter worth about $30,000. EverSource Wealth Advisors LLC grew its position in Celsius by 3,116.7% during the 1st quarter. EverSource Wealth Advisors LLC now owns 386 shares of the company’s stock worth $32,000 after acquiring an additional 374 shares during the last quarter. Livforsakringsbolaget Skandia Omsesidigt acquired a new stake in Celsius during the 3rd quarter valued at $34,000. Signaturefd LLC raised its position in Celsius by 48.3% in the 3rd quarter. Signaturefd LLC now owns 1,160 shares of the company’s stock valued at $36,000 after purchasing an additional 378 shares during the last quarter. Finally, Benjamin F. Edwards & Company Inc. boosted its stake in Celsius by 353.1% in the second quarter. Benjamin F. Edwards & Company Inc. now owns 648 shares of the company’s stock worth $37,000 after purchasing an additional 505 shares in the last quarter. Institutional investors and hedge funds own 60.95% of the company’s stock.
About Celsius
Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.
Read More
- Five stocks we like better than Celsius
- What Does Downgrade Mean in Investing?
- Observability Wars: Datadog and Dynatrace Vie for Data Dominance
- What Are Dividend Champions? How to Invest in the Champions
- Airbnb Stock Attracts Attention With Strong Cash Flow Strategy
- What is the Dogs of the Dow Strategy? Overview and Examples
- MarketBeat Week in Review – 11/4 – 11/8
Receive News & Ratings for Celsius Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celsius and related companies with MarketBeat.com's FREE daily email newsletter.